heiBIB: Hose, Dirk

Hose, Dirk Dr.Universität HeidelbergHeidelberg

Publikationsliste einschränken

Publikationsjahre

Publikationstypen

Liste

Sprache

englisch (191)
deutsch (12)

Co-Autoren (Uni Heidelberg)

mehr ...

Co-Autoren (extern)

mehr ...

Publikationen in heiBIB

Hose, Dirk: Correction: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma / Dirk Hose, Seemun Ray, Sina Rößler, Ulrich Thormann, Reinhard Schnettler, Kim de Veirman, Thaqif El … , 24 January 2025. - 1 S.
In: Journal of hematology & oncology, ISSN 1756-8722. 18(2025), Artikel-ID 11, Seite 1
DOI: 10.1186/s13045-025-01663-9
Hose, Dirk: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma / Dirk Hose, Seemun Ray, Sina Rößler, Ulrich Thormann, Reinhard Schnettler, Kim de Veirman, Thaqif El … , 18 December 2024. - 20 S. : Illustrationen
In: Journal of hematology & oncology, ISSN 1756-8722. 17(2024), Artikel-ID 128, Seite 1-20
DOI: 10.1186/s13045-024-01636-4
Kriegsmann, Katharina: CD8+ CD28- regulatory T cells after induction therapy predict progression-free survival in myeloma patients : results from the GMMG-HD6 multicenter phase III study / Katharina Kriegsmann, Gigi Nu Hoang Quy Ton, Mohamed H. S. Awwad, Axel Benner, Uta Bertsch, Britta B… , 2024. - 5 S. : Diagramme
In: Leukemia, ISSN 1476-5551. 38(2024), 7, Seite 1621-1625
DOI: 10.1038/s41375-024-02290-y
Hummel, Manuela: Quantitative integrative survival prediction in multiple myeloma patients treated with bortezomib-based induction, high-dose therapy and autologous stem cell transplantation / Manuela Hummel; Thomas Hielscher; Martina Emde-Rajaratnam; Hans Salwender; Susanne Beck; Christof Sc… , July 10, 2024. - 12 S. : Illustrationen
In: JCO precision oncology, ISSN 2473-4284. 8(2024), Artikel-ID e2300613, Seite 1-12
DOI: 10.1200/PO.23.00613
Seckinger, Anja: Molecular long-term analysis of the GMMG-HD4 trial in multiple myeloma$patterns of Association of Chromosomal Aberrations with response and proliferation determining survival in selecting treatments in view of limited resources in low- and middle-income countries / Anja Seckinger, Hans Salwender, Hans Martin, Christof Scheid, Thomas Hielscher, Uta Bertsch, Manuela… , 11 June 2024. - 19 S. : Illustrationen
In: International journal of molecular sciences, ISSN 1422-0067. 25(2024), 12, Artikel-ID 6431, Seite 1-19
DOI: 10.3390/ijms25126431
Mai, Elias K.: Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6) : results from a randomised, phase 3 trial / Elias K Mai, Hartmut Goldschmidt, Kaya Miah, Uta Bertsch, Britta Besemer, Mathias Hänel, Julia Krzyk… , February 2024. - 13 S.
In: The lancet, ISSN 2352-3026. 11(2024), 2, Seite e101-e113
DOI: 10.1016/S2352-3026(23)00366-6
Emde-Rajaratnam, Martina: RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma / Martina Emde-Rajaratnam, Susanne Beck, Vladimir Benes, Hans Salwender, Uta Bertsch, Christoph Scheid… , 15 November 2023. - 18 S. : Illustrationen
In: Frontiers in immunology, ISSN 1664-3224. 14(2023) vom: Nov., Artikel-ID 1286700, Seite 1-18
DOI: 10.3389/fimmu.2023.1286700
Maichl, Daniela: Identification of NOTCH-driven matrisome-associated genes as prognostic indicators of multiple myeloma patient survival / Daniela Simone Maichl, Julius Arthur Kirner, Susanne Beck, Wen-Hui Cheng, Melanie Krug, Martin Kuric… , 05 September 2023. - 6 S. : Illustrationen
In: Blood cancer journal, ISSN 2044-5385. 13(2023), Artikel-ID 134, Seite 1-6
DOI: 10.1038/s41408-023-00907-6
Mai, Elias K.: Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma / Elias K. Mai, Stefanie Huhn, Kaya Miah, Alexandra M. Poos, Christof Scheid, Katja C. Weisel, Uta Ber… , 04 January 2023. - 9 S.
In: Blood cancer journal, ISSN 2044-5385. 13(2023), 1, Artikel-ID 1, Seite 1-9
DOI: 10.1038/s41408-022-00772-9
Stroh, Jacob: MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma / Jacob Stroh, Anja Seckinger, Michael Heider, Martina Rudelius, Ruth Eichner, Markus Schick, Jolanta … , 18 January 2022. - 6 S.
In: Blood advances, ISSN 2473-9537. 6(2022), 2, Seite 515-520
DOI: 10.1182/bloodadvances.2021005532
Basset, Marco: Lenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis : results from a large cohort of patients with long follow-up / Marco Basset, Christoph R. Kimmich, Nicholas Schreck, Julia Krzykalla, Tobias Dittrich, Kaya Veelken… , 3 August 2021. - 14 S.
In: British journal of haematology, ISSN 1365-2141. 195(2021), 2, Seite 230-243
DOI: 10.1111/bjh.17685
Klein, Eva-Maria: Prognostic impact of serum free light chain ratio normalization in patients with multiple myeloma treated within the GMMG-MM5 trial / Eva-Maria Klein, Diana Tichy, Hans J. Salwender, Elias K. Mai, Jan Duerig, Katja C. Weisel, Axel Ben… , 28 September 2021. - 16 S.
In: Cancers, ISSN 2072-6694. 13(2021), 19, Artikel-ID 4856, Seite 1-16
DOI: 10.3390/cancers13194856
Khandanpour, Cyrus: Prevalence of the GFI1-36N SNP in multiple myeloma patients and its impact on the prognosis / Cyrus Khandanpour, Christine Eisfeld, Subbaiah Chary Nimmagadda, Marc S. Raab, Niels Weinhold, Anja … , 25 October 2021. - 8 S.
In: Frontiers in oncology, ISSN 2234-943X. 11(2021) vom: 25. Okt., Artikel-ID 757664, Seite 1-8
DOI: 10.3389/fonc.2021.757664
Tirier, Stephan Marius: Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomics / Stephan M. Tirier, Jan-Philipp Mallm, Simon Steiger, Alexandra M. Poos, Mohamed H. S. Awwad, Nicola … , 29 November 2021. - 16 S.
In: Nature Communications, ISSN 2041-1723. 12(2021), Artikel-ID 6960, Seite 1-16
DOI: 10.1038/s41467-021-26951-z
Mai, Elias K.: Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age / Elias K. Mai, Kaya Miah, Uta Bertsch, Jan Dürig, Christof Scheid, Katja C. Weisel, Christina Kunz, M… , 2021. - 14 S.
In: Leukemia, ISSN 1476-5551. 35(2021), 3, Seite 809-822
DOI: 10.1038/s41375-020-0976-9
Bärtsch, Marc-Andrea: Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma / Marc-Andrea Baertsch, Elias K. Mai, Thomas Hielscher, Uta Bertsch, Hans J. Salwender, Markus Munder,… , 07 January 2021. - 10 S.
In: Blood cancer journal, ISSN 2044-5385. 11(2021), Artikel-ID 1, Seite 1-10
DOI: 10.1038/s41408-020-00390-3
Goldschmidt, Hartmut: Response-adapted lenalidomide maintenance in newly diagnosed myeloma : results from the phase III GMMG-MM5 trial / Hartmut Goldschmidt, Elias K. Mai, Jan Dürig, Christof Scheid, Katja C. Weisel, Christina Kunz, Uta … , 7 February 2020. - 13 S.
In: Leukemia, ISSN 1476-5551. 34(2020), 7, Seite 1853-1865
DOI: 10.1038/s41375-020-0724-1
Volpin, Valentina: CAMK1D triggers immune resistance of human tumor cells refractory to Anti-PD-L1 treatment / Valentina Volpin, Tillmann Michels, Antonio Sorrentino, Ayse N. Menevse, Gertrud Knoll, Madlen Ditz,… , July 14, 2020. - 17 S.
In: Cancer immunology research, ISSN 2326-6074. 8(2020), 9, Seite 1163-1179
DOI: 10.1158/2326-6066.CIR-19-0608
Hájek, Roman: Identification of patients with smouldering multiple myeloma at ultra-high risk of progression using serum parameters : the Czech Myeloma Group model / Roman Hájek, Viera Sandecka, Ivan Špička, Marc Raab, Hartmut Goldschmidt, Susanne Beck, Jiří Minařík… , 12 March 2020. - 9 S.
In: British journal of haematology, ISSN 1365-2141. 190(2020), 2, Seite 189-197
DOI: 10.1111/bjh.16572
Kimmich, Christoph: Daratumumab for systemic AL amyloidosis : prognostic factors and adverse outcome with nephrotic-range albuminuria / Christoph R. Kimmich, Tobias Terzer, Axel Benner, Tobias Dittrich, Kaya Veelken, Alexander Carpinte… , April 30, 2020. - 14 S.
In: Blood, ISSN 1528-0020. 135(2020), 18, Seite 1517-1530
DOI: 10.1182/blood.2019003633
Goldschmidt, Hartmut: Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma : the randomized GMMG phase III trial ReLApsE / Hartmut Goldschmidt, Marc-Andrea Baertsch, Jana Schlenzka, Natalia Becker, Christina Habermehl, Thom… , 21 July 2020. - 11 S.
In: Leukemia, ISSN 1476-5551. 35(2021), 4, Seite 1134-1144
DOI: 10.1038/s41375-020-0948-0
Merz, Maximilian: Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma / Maximilian Merz, Thomas Hielscher, David Schult, Elias K. Mai, Marc S. Raab, Jens Hillengass, Anja S… , [2020]. - 5 S. : Diagramme
In: Leukemia, ISSN 1476-5551. 34(2020), 4, Seite 1192-1196
DOI: 10.1038/s41375-019-0634-2
Boussac, Hugues de: Kinome expression profiling to target new therapeutic avenues in multiple myeloma / Hugues de Boussac, Angélique Bruyer, Michel Jourdan, Anke Maes, Nicolas Robert, Claire Gourzones, La… , 2020. - 12 S.
In: Haematologica, ISSN 1592-8721. 105(2020), 3, Seite 784-795
DOI: 10.3324/haematol.2018.208306
Emde-Rajaratnam, Martina: RNA-sequencing based assessment of targets, risk and long term survival for personalized treatment of multiple myeloma / Martina Emde, Susanne Beck, Vladimir Benes, Jerome Moreaux, PhD, Anja Seckinger, Dirk Hose, MD, 13 November 2019. - 2 S. : Illustrationen
In: Blood, ISSN 1528-0020. 134(2019), Supplement_1, Artikel-ID 1801, Seite 1-2
DOI: 10.1182/blood-2019-131159
Beck, Susanne: Prediction of malingant plasma cell biology related survival in AL-amyloidosis / Susanne Beck, Martina Emde, Jerome Moreaux, Anja Seckinger, Dirk Hose, 13 November 2019. - 3 S.
In: Blood, ISSN 1528-0020. 134(2019), Supplement_1, Artikel-ID 3078, Seite 1-3
DOI: 10.1182/blood-2019-131161
Stroh, Jacob: MCT1 as molecularly validated predictive marker for lenalidomide-maintenance therapy in multiple myeloma / Jacob Stroh, Anja Seckinger, Michael Heider, Ruth Eichner, Martina Emde, Hans Salwender, Uta Bertsch… , 13 November 2019. - 3 S.
In: Blood, ISSN 1528-0020. 134(2019), Supplement_1, Artikel-ID 3187, Seite 1-3
DOI: 10.1182/blood-2019-130734
Darche, Fabrice Fernand: Pacemaker cell characteristics of differentiated and HCN4-transduced human mesenchymal stem cells / Fabrice F. Darche, Rasmus Rivinius, Eva Köllensperger, Uwe Leimer, Günter Germann, Anja Seckinger, D… , 07 July 2019. - 16 S.
In: Life sciences, ISSN 1879-0631. 232(2019), Artikel-ID 116620, Seite 1-16
DOI: 10.1016/j.lfs.2019.116620
Merz, Maximilian: Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma / Maximilian Merz, Thomas Hielscher, Elias Karl Mai, Anja Seckinger, Dirk Hose, Anna Jauch, Sandra Sau… , 27 August 2019. - 5 S.
In: Blood cancer journal, ISSN 2044-5385. 9(2019,9) Artikel-Nummer 71, 5 Seiten
DOI: 10.1038/s41408-019-0235-3
Weisel, Katja: Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone : results of the phase II PERSPECTIVE multiple myeloma trial / Katja C. Weisel, Christof Scheid, Manola Zago, Britta Besemer, Elias K. Mai, Mathias Haenel, Jan Due… , 08 April 2019. - 4 S.
In: Blood cancer journal, ISSN 2044-5385. 9(2019) Artikel-Nummer 45, 4 Seiten
DOI: 10.1038/s41408-019-0206-8
Posa, Francesca: Copresentation of BMP-6 and RGD ligands enhances cell adhesion and BMP-mediated signaling / Francesca Posa, Anna Luise Grab, Volker Martin, Dirk Hose, Anja Seckinger, Giorgio Mori, Slobodan Vu… , 15 December 2019. - 16 S.
In: Cells, ISSN 2073-4409. 8(2019,12) Artikel-Nummer 1646, 16 Seiten
DOI: 10.3390/cells8121646
Grab, Anna Luise: Hyaluronan hydrogels delivering BMP-6 for local targeting of malignant plasma cells and osteogenic differentiation of mesenchymal stromal cells / Anna Luise Grab, Anja Seckinger, Patrick Horn, Dirk Hose, Elisabetta Ada Cavalcanti-Adam, 11 July 2019. - 13 S.
In: Acta biomaterialia, ISSN 1878-7568. 96(2019), Seite 258-270
DOI: 10.1016/j.actbio.2019.07.018
Hose, Dirk: Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial / Dirk Hose, Susanne Beck, Hans Salwender, Martina Emde, Uta Bertsch, Christina Kunz, Christoph Scheid… . -
London: BioMed Central, 09 Aug. 2019. - 1 Online-Ressource (12 Seiten)
Salwender, Hans: Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6 : a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma / Hans Salwender, Uta Bertsch, Katja Weisel, Jan Duerig, Christina Kunz, Axel Benner, Igor W. Blau, Ma… . -
London: BioMed Central, 2019. - 1 Online-Ressource (11 Seiten)
Hose, Dirk: Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial / Dirk Hose, Susanne Beck, Hans Salwender, Martina Emde, Uta Bertsch, Christina Kunz, Christoph Scheid… , 26 June 2019. - 12 S.
In: Journal of hematology & oncology, ISSN 1756-8722. 12(2019), Artikel-ID 65, Seite 1-12
DOI: 10.1186/s13045-019-0750-5
Mai, Elias K.: Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma / Elias K. Mai, Thomas Hielscher, Uta Bertsch, Jana Schlenzka, Hans J. Salwender, Markus Munder, Chris… , 2019. - 4 S.
In: Leukemia, ISSN 1476-5551. 33(2019), 1, Seite 258-261
DOI: 10.1038/s41375-018-0195-9
Salwender, Hans: Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6 : a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma / Hans Salwender, Uta Bertsch, Katja Weisel, Jan Duerig, Christina Kunz, Axel Benner, Igor W. Blau, Ma… , 28 May 2019. - 11 S.
In: BMC cancer, ISSN 1471-2407. 19(2019) Artikel-Nummer 504, 11 Seiten
DOI: 10.1186/s12885-019-5600-x
Kriegsmann, Katharina: Cereblon-binding proteins expression levels correlate with hyperdiploidy in newly diagnosed multiple myeloma patients / Katharina Kriegsmann, Marc-Andrea Baertsch, Mohamed H. S. Awwad, Maximilian Merz, Dirk Hose, Anja Se… , 29 January 2019. - 10 S.
In: Blood cancer journal, ISSN 2044-5385. 9(2019), 2, Artikel-ID 13, Seite 1-10
DOI: 10.1038/s41408-019-0174-z
Seckinger, Anja: AL amyloidosis - pathogenesis and prognosis are determined by the amyloidogenic potential of the light chain and the molecular characteristics of malignant plasma cells / Anja Seckinger, Ute Hegenbart, Susanne Beck, Martina Emde, Tilmann Bochtler, Christoph Kimmich, Cars… , 29 November 2018. - 4 S.
In: Blood, ISSN 1528-0020. 132(2018), Supplement_1, Artikel-ID 187, Seite 1-4
DOI: 10.1182/blood-2018-187
Seckinger, Anja: Treatment response and long-term survival in multiple myeloma in the GMMG-HD4 trial : neither profit all molecular entities alike, nor are remissions to different regimen equal / Anja Seckinger, Hans Jürgen Salwender, MD, Hans Martin, MD, Christof Scheid, Thomas Hielscher, Uta B… , 29 November 2018. - 4 S.
In: Blood, ISSN 1528-0020. 132(2018), Supplement_1, Artikel-ID 4485, Seite 1-4
DOI: 10.1182/blood-2018-99-113284
Seckinger, Anja: Vorhabenbezeichnung: CLIOMMICS - clinically-applicable, omics-based assessment of survival, side effects, and targets in multiple myeloma : Schlussbericht : Laufzeit des Vorhabens: 01.09.2016-31.08.2018 / Zuwendungsempfänger: Ruprechts-Karls-Universität Heidelberg, Medizinischer Fakultät und Universitäts… . -
[Heidelberg]: Ruprechts-Karls-Universität Heidelberg, [2018?]. - 1 Online-Ressource (15 Seiten, 763,94 KB) : Diagramme
DOI: 10.2314/GBV:1663002541
Seckinger, Anja: Vorhabenbezeichnung: CLIOMMICS - clinically-applicable, omics-based assessment of survival, side effects, and targets in multiple myeloma : Schlussbericht : Laufzeit des Vorhabens: 01.09.2016-31.08.2018 / Zuwendungsempfänger: Ruprechts-Karls-Universität Heidelberg, Medizinischer Fakultät und Universitäts… . -
[Heidelberg]: Ruprechts-Karls-Universität Heidelberg, [2018?]. - 15 ungezählte Blätter : Diagramme
Merz, Maximilian: Cytogenetic abnormalities in monoclonal gammopathy of undetermined significance / Maximilian Merz, Thomas Hielscher, Korbinian Hoffmann, Anja Seckinger, Dirk Hose, Marc S. Raab, Jens… , 6 July 2018. - 3 S.
In: Leukemia, ISSN 1476-5551. 32(2018), 12, Seite 2717-2719
DOI: 10.1038/s41375-018-0202-1
Bochtler, Tilmann: Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myeloma / Tilmann Bochtler, Maximilian Merz, Thomas Hielscher, Martin Granzow, Korbinian Hoffmann, Alwin Kräme… , 2018. - 12 S.
In: Blood advances, ISSN 2473-9537. 2(2018), 20, Seite 2607-2618
DOI: 10.1182/bloodadvances.2018023200
Herviou, Laurie: PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs / Laurie Herviou, Alboukadel Kassambara, Stéphanie Boireau, Nicolas Robert, Guilhem Requirand, Carsten… , 03 October 2018. - 18 S. : Diagramme
In: Clinical epigenetics, ISSN 1868-7083. 10(2018), Artikel-ID 121, Seite 1-18
DOI: 10.1186/s13148-018-0554-4
Nair, Shiny: Antigen-mediated regulation in monoclonal gammopathies and myeloma / Shiny Nair, Joel Sng, Chandra Sekhar Boddupalli, Anja Seckinger, Marta Chesi, Mariateresa Fulcinit, … , April 19, 2018. - 14 S.
In: JCI insight, ISSN 2379-3708. 3(2018,8) Artikel-Nummer e98259, 14 Seiten
DOI: 10.1172/jci.insight.98259
Kriegsmann, Katharina: Quantification of number of CD38 sites on bone marrow plasma cells in patients with light chain amyloidosis and smoldering multiple myeloma / Katharina Kriegsmann, Tobias Dittrich, Brigitte Neuber, Mohamed H. S. Awwad, Ute Hegenbart, Hartmut … , 25 March 2018. - 10 S.
In: Cytometry, ISSN 1552-4957. 94(2018), 5, Seite 767-776
DOI: 10.1002/cyto.b.21636
Requirand, Guilhem: BrdU incorporation in multiparameter flow cytometry : a new cell cycle assessment approach in multiple myeloma / Guilhem Requirand, Nicolas Robert, Stéphanie Boireau, Laure Vincent, Anja Seckinger, Salaheddine Bou… , 2019. - 6 S.
In: Cytometry, ISSN 1552-4957. 96(2019), 3, Seite 209-214
DOI: 10.1002/cyto.b.21730
Bruyer, Angelique: DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells / Angelique Bruyer, Ken Maes, Laurie Herviou, Alboukadel Kassambara, Anja Seckinger, Guillaume Cartron… , 2 March 2018. - 12 S.
In: British journal of cancer, ISSN 1532-1827. 118(2018), 8, Seite 1062-1073
DOI: 10.1038/s41416-018-0025-x
Tsiklauri, Lali: Visfatin alters the cytokine and matrix-degrading enzyme profile during osteogenic and adipogenic MSC differentiation / L. Tsiklauri, J. Werner, M. Kampschulte, K.W. Frommer, L. Berninger, M. Irrgang, K. Glenske, D. Hose… , 14 June 2018. - 11 S.
In: Osteoarthritis and cartilage, ISSN 1522-9653. 26(2018), 9, Seite 1225-1235
DOI: 10.1016/j.joca.2018.06.001
Gu, Chunyan: Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcome / Chunyan Gu, Carol Holman, Ramakrishna Sompallae, Xuefang Jing, Michael Tomasson, Dirk Hose, Anja Sec… , 15 February 2018. - 5 S.
In: Blood cancer journal, ISSN 2044-5385. 8(2018,2) Artikel-Nummer 22, 5 Seiten
DOI: 10.1038/s41408-018-0060-0
Goldschmidt, Hartmut: Bortezomib before and after high-dose therapy in myeloma : long-term results from the phase III HOVON-65/GMMG-HD4 trial / H. Goldschmidt, H.M Lokhorst, E.K. Mai, B. van der Holt, I.W. Blau, S. Zweegman, K.C. Weisel, E. Vel… , 2018. - 8 S.
In: Leukemia, ISSN 1476-5551. 32(2018), Seite 383-390
Seckinger, Anja: CD38 as immunotherapeutic target in light chain amyloidosis and multiple myeloma : association with molecular entities, risk, survival, and mechanisms of upfront resistance / Anja Seckinger, Jens Hillengass, Martina Emde, Susanne Beck, Christoph Kimmich, Tobias Dittrich, Mic… , 20 July 2018. - 15$
In: Frontiers in immunology, ISSN 1664-3224. 9(2018), Artikel-ID 1676, Seite 1-15
DOI: 10.3389/fimmu.2018.01676
Mohr, Marcel: Quantification of plasma cell dynamics using mathematical modelling / Marcel Mohr, Dirk Hose, Anja Seckinger and Anna Marciniak-Czochra, 2018. - 15 S.
In: Royal Society Open Science, ISSN 2054-5703. 5(2018,1) Artikel-Nummer 170759, 15 Seiten
DOI: 10.1098/rsos.170759
Seckinger, Anja: Asymptomatic multiple myeloma : molecular background of progression and prognosis / Anja Seckinger, Anna Jauch, Martina Emde, Susanne Beck, Marcel Mohr, Martin Granzow, Thomas Hielsche… , February 2017. - 2 S.
In: Clinical lymphoma, myeloma & leukemia, ISSN 2152-2669. 17(2017), 1, Supplement vom: Feb., Seite e9-e10
DOI: 10.1016/j.clml.2017.03.016
Seckinger, Anja: CLIOMMICS - Clinically-applicable, omics-based assessment of survival, side effects, and targets in multiple myeloma : Schlussbericht : Laufzeit des Vorhabens: 01.09.2013-31.08.2016 / Zuwendungsempfänger: Ruprecht-Karls-Universität Heidelberg, Medizinische Fakultät und Universitätskl… . -
Heidelberg: Ruprecht-Karls-Universität Heidelberg, Medizinische Fakultät und Universitätsklinikum Heidelberg, Sektion Multiples Myelom, [2017?]. - 1 Online-Ressource (17 Seiten, 302,53 KB)
DOI: 10.2314/GBV:89050766X
Seckinger, Anja: CLIOMMICS - Clinically-applicable, omics-based assessment of survival, side effects, and targets in multiple myeloma : Schlussbericht : Laufzeit des Vorhabens: 01.09.2013-31.08.2016 / Zuwendungsempfänger: Ruprecht-Karls-Universität Heidelberg, Medizinische Fakultät und Universitätskl… . -
Heidelberg: Ruprecht-Karls-Universität Heidelberg, Medizinische Fakultät und Universitätsklinikum Heidelberg, Sektion Multiples Myelom, [2017?]. - 17 ungezählte Seiten
De Smedt, Eva: Loss of RASSF4 expression in multiple myeloma promotes RAS-driven malignant progression / Eva De Smedt, Ken Maes, Stefaan Verhulst, Hui Lui, Alboukadel Kassambara, Anke Maes, Nicolas Robert,… , December 19, 2017. - 14 S.
In: Cancer research, ISSN 1538-7445. 78(2018), 5, Seite 1155-1168
DOI: 10.1158/0008-5472.CAN-17-1544
Kruppke, Benjamin: Drug release as a function of bioactivity, incubation regime, liquid, and initial load : release of bortezomib from calcium phosphate-containing silica/collagen xerogels / Benjamin Kruppke, Dirk Hose, Reinhard Schnettler, Anja Seckinger, Sina Rößler, Thomas Hanke, Sascha … , 2018. - 9 S.
In: Journal of biomedical materials research, ISSN 1552-4981. 106(2018), 3, Seite 1165-1173
DOI: 10.1002/jbm.b.33931
Khassawna, Thaqif el-: Osteocyte regulation of receptor activator of NF-[kappa]B ligand/osteoprotegerin in a sheep model of osteoporosis / Thaqif El Khassawna, Felix Merboth, Deeksha Malhan, Wolfgang Böcker, Diaa E. S. Daghma, Sabine Stoet… , August 2017. - 14 S.
In: The American journal of pathology, ISSN 1525-2191. 187(2017), 8, Seite 1686-1699
DOI: 10.1016/j.ajpath.2017.04.005
Fan, Fengjuan: The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment / F. Fan, M. H. Bashari, E. Morelli, G. Tonon, S. Malvestiti, S. Vallet, M. Jarahian, A. Seckinger, D.… , July 2017. - 12 S.
In: Leukemia, ISSN 1476-5551. 31(2017), 7, Seite 1570-1581
DOI: 10.1038/leu.2016.358
Hegenbart, Ute: Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis : results of a prospective phase 2 study with long-term follow up / Ute Hegenbart, Tilmann Bochtler, Axel Benner, Natalia Becker, Christoph Kimmich, Arnt V. Kristen, Jö… , 2017. - 8 S.
In: Haematologica, ISSN 1592-8721. 102(2017), 8, Seite 1424-1431
DOI: 10.3324/haematol.2016.163246
Merz, Maximilian: Longitudinal fluorescence in situ hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantation / Maximilian Merz, Anna Jauch, Thomas Hielscher, Elias K. Mai, Anja Seckinger, Dirk Hose, Uta Bertsch,… , May 11, 2017. - 7 S.
In: Haematologica, ISSN 1592-8721. 102(2017), 8, Seite 1432-1438
DOI: 10.3324/haematol.2017.168005
De Veirman, Kim: Extracellular S100A9 protein in bone marrow supports multiple myeloma survival by stimulating angiogenesis and cytokine secretion / Kim De Veirman, Nathan De Beule, Ken Maes, Eline Menu, Elke De Bruyne, Hendrik De Raeve, Karel Fosti… , September 13, 2017. - 8 S.
In: Cancer immunology research, ISSN 2326-6074. 5(2017), 10, Seite 839-846
DOI: 10.1158/2326-6066.CIR-17-0192
Viziteu, Elena: RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma / E. Viziteu, B. Klein, J. Basbous, Y.-L. Lin, C. Hirtz, C. Gourzones, L. Tiers, A. Bruyer, L. Vincent… , 10 February 2017. - 10 S. : Illustrationen
In: Leukemia, ISSN 1476-5551. 31(2017), 10, Seite 2104-2113
DOI: 10.1038/leu.2017.54
Seckinger, Anja: Target expression, generation, preclinical activity, and pharmacokinetics of the BCMA-T cell bispecific antibody EM801 for multiple myeloma treatment / Anja Seckinger, Jose Antonio Delgado, Samuel Moser, Laura Moreno, Brigitte Neuber, Anna Grab, Susann… , 2017. - 15 S.
In: Cancer cell, ISSN 1878-3686. 31(2017), 3, Seite 396-410
DOI: 10.1016/j.ccell.2017.02.002
Schulze, Felix: A tissue-based approach to selection of reference genes for quantitative real-time PCR in a sheep osteoporosis model / Felix Schulze; Deeksha Malhan; Thaqif EL Khassawna; Christian Heiss; Anja Seckinger; Dirk Hose and A… . -
London ; Berlin ; Heidelberg: BioMed Central ; Springer, 30 Mai 2018. - 1 Online-Ressource (8 Seiten)
DOI: 10.1186/s12864-017-4356-4
Schmitt, Michael: Frequency of expression and generation of T-cell responses against antigens on multiple myeloma cells in patients included in the GMMG-MM5 trial / Michael Schmitt, Angela G. Hückelhoven, Michael Hundemer, Anita Schmitt, Susanne Lipp, Martina Emde,… , 2017. - 16 S.
In: OncoTarget, ISSN 1949-2553. 8(2017), 49, Seite 84847-84862
DOI: 10.18632/oncotarget.11215
Schulze, Felix: A tissue-based approach to selection of reference genes for quantitative real-time PCR in a sheep osteoporosis model / Felix Schulze, Deeksha Malhan, Thaqif El Khassawna, Christian Heiss, Anja Seckinger, Dirk Hose and A… , 2017, Dec 19. - 9 S.
In: BMC genomics, ISSN 1471-2164. 18(2017) Artikel-Nummer 975, 9 Seiten
DOI: 10.1186/s12864-017-4356-4
Granzow, Martin: Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect : first results from a genome-wide copy number array analysis / Martin Granzow, Ute Hegenbart, Katrin Hinderhofer, Dirk Hose, Anja Seckinger, Tilmann Bochtler, Kari… , July 2017. - 10 S.
In: Haematologica, ISSN 1592-8721. 102(2017), 7, Seite 1281-1290
DOI: 10.3324/haematol.2016.160721
Alaterre, Elina: CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma / Elina Alaterre, Sebastien Raimbault, Hartmut Goldschmidt, Salahedine Bouhya, Guilhem Requirand, Nico… , October 30, 2017. - 14 S.
In: OncoTarget, ISSN 1949-2553. 8(2017), 58, Seite 98931-98944
DOI: 10.18632/oncotarget.22131
Flores, Blanca: From bench to bedside : a view on bioinformatics pipelines / Blanca Flores, Dirk Hose, Anja Seckinger, Petra Knaup, Matthias Ganzinger, [2017]. - 4 S.
In: MEDINFO 2017. (2017), Seite 375-378
DOI: 10.3233/978-1-61499-830-3-375
Seckinger, Anja: Asymptomatic multiple myeloma : background of progression, evolution, and prognosis / Anja Seckinger, MD, Anna Jauch, PhD, Martina Emde, Susanne Beck, Marcel Mohr, Martin Granzow, PhD, … , 2 December 2016. - 3 S.
In: Blood, ISSN 1528-0020. 128(2016), 22, Artikel-ID 235, Seite 1-3
DOI: 10.1182/blood.V128.22.235.235
Krämer, Isabelle: Lenalidomide enhances myeloma-specific T-cell responses in vivo and in vitro / Isabelle Krämer, Melanie Engelhardt, Sabrina Fichtner, Brigitte Neuber, Sergej Medenhoff, Uta Bertsc… , 31 May 2016. - 10 S.
In: OncoImmunology, ISSN 2162-402X. 5(2016,5) Artikel-Nummer e1139662, 10 seiten
DOI: 10.1080/2162402X.2016.1139662
Schoenhals, Matthieu: Forced KLF4 expression increases the generation of mature plasma cells and uncovers a network linked with plasma cell stage / Matthieu Schoenhals, Michel Jourdan, Anja Seckinger, Véronique Pantesco, Dirk Hose, Alboukadel Kassa… , 21 Jun 2016. - 10 S.
In: Cell cycle, ISSN 1551-4005. 15(2016), 14, Seite 1919-1928
DOI: 10.1080/15384101.2016.1191709
Viziteu, Elena: Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myeloma / Elena Viziteu, Camille Grandmougin, Hartmut Goldschmidt, Anja Seckinger, Dirk Hose, Bernard Klein an… , 11 February 2016. - 5 S.
In: British journal of cancer, ISSN 1532-1827. 114(2016), 5, Seite 519-523
DOI: 10.1038/bjc.2016.20
Weinhold, Niels: Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma / Niels Weinhold, Desiree Kirn, Anja Seckinger, Thomas Hielscher, Martin Granzow, Uta Bertsch, Gerlind… , March 2016. - 4 S.
In: Haematologica, ISSN 1592-8721. 101(2016), 3, Seite e116-e119
DOI: 10.3324/haematol.2015.136929
Gu, C.: FOXM1 is a therapeutic target for high-risk multiple myeloma / C. Gu, Y. Yang, R. Sompallae, H. Xu, V.S. Tompkins, C. Holman, D. Hose, H. Goldschmidt, G. Tricot, F… , 26 January 2016. - 10 S.
In: Leukemia, ISSN 1476-5551. 30(2016), 4, Seite 873-882
DOI: 10.1038/leu.2015.334
Bärtsch, Marc-Andrea: Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE : a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma / Marc-Andrea Baertsch, Jana Schlenzka, Elias K. Mai, Maximilian Merz, Jens Hillengaß, Marc S. Raab, D… , 25 April 2016. - 10 S.
In: BMC cancer, ISSN 1471-2407. 16(2016) Artikel-Nummer 290, 10 Seiten
DOI: 10.1186/s12885-016-2321-2
Bochtler, Tilmann: Prognostic impact of cytogenetic aberrations in AL amyloidosis patients after high-dose melphalan : a long-term follow-up study / Tilmann Bochtler, Ute Hegenbart, Christina Kunz, Axel Benner, Christoph Kimmich, Anja Seckinger, Dir… , 2 June 2016. - 9 S.
In: Blood, ISSN 1528-0020. 128(2016), 4, Seite 594-602
DOI: 10.1182/blood-2015-10-676361
Mai, Elias K.: Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma : analyzing surrogates of tumour mass and biology / Elias K. Mai, Thomas Hielscher, Jost K. Kloth, Maximilian Merz, Sofia Shah, Michaela Hillengass, Bar… , 15 January 2016. - 10 S.
In: European radiology, ISSN 1432-1084. 26(2016), 11, Seite 3939-3948
DOI: 10.1007/s00330-015-4195-0
Merz, Maximilian: Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial / Maximilian Merz, Hans Salwender, Mathias Haenel, Elias K. Mai, Uta Bertsch, Christina Kunz, Thomas H… , December 2016. - 3 S.
In: Haematologica, ISSN 1592-8721. 101(2016), 12, Seite e485-e487
DOI: 10.3324/haematol.2016.151266
Merz, Maximilian: Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myeloma / Maximilian Merz, Thomas Hielscher, Anja Seckinger, Dirk Hose, Elias K. Mai, Marc S. Raab, Hartmut Go… , 10 August 2016. - 5 S.
In: American journal of hematology, ISSN 1096-8652. 91(2016), 11, Seite E473-E477
DOI: 10.1002/ajh.24533
Bärtsch, Marc-Andrea: Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE : a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma / Marc-Andrea Bärtsch, Jana Schlenzka, Elias Karl Mai, Maximilian Merz, Jens Hillengaß, Marc S. Raab, … . -
London; Berlin; Heidelberg: BioMed Central; Springer, 2016. - 1 Online-Ressource (10 Seiten)
Hose, Dirk: Clinical applicable multimodal prediction of survival in multiple myeloma (CAMPSIMM) : Schlussbericht : Laufzeit des Vorhabens: 01.02.2012-31.01.2015 / Zuwendungsempfänger: Ruprechts-Karls-Universität - Medizinische Fakultät und Universitätsklinikum He… . -
[Heidelberg]: [Universitätsklinikum Heidelberg, Sektion Multiples Myelom], [2015?]. - 13 ungezählte Seiten
Hose, Dirk: Clinical applicable multimodal prediction of survival in multiple myeloma (CAMPSIMM) : Schlussbericht : Laufzeit des Vorhabens: 01.02.2012-31.01.2015 / Zuwendungsempfänger: Ruprechts-Karls-Universität - Medizinische Fakultät und Universitätsklinikum He… . -
[Heidelberg]: [Universitätsklinikum Heidelberg, Sektion Multiples Myelom], [2015?]. - 1 Online-Ressource (13 Seiten, 216 KB)
DOI: 10.2314/GBV:879903279
Fichtner, Sabrina: Association of antigen-specific T-cell responses with antigen expression and immunoparalysis in multiple myeloma / Sabrina Fichtner, Dirk Hose, Melanie Engelhardt, Tobias Meißner, Brigitte Neuber, Fatime Krasniqi, M… , January 21, 2015. - 10 S.
In: Clinical cancer research, ISSN 1557-3265. 21(2015), 7, Seite 1712-1721
DOI: 10.1158/1078-0432.CCR-14-1618
Lub, Susanne: Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells / Susanne Lub, Anke Maes, Ken Maes, Kim De Veirman, Elke De Bruyne, Eline Menu, Karel Fostier, Albouka… , December 26, 2015. - 15 S.
In: OncoTarget, ISSN 1949-2553. 7(2015), 4, Seite 4062-4076
DOI: 10.18632/oncotarget.6768
Merz, Maximilian: Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma : results of a prospective DCE-MRI study / Maximilian Merz, Thomas M. Moehler, Judith Ritsch, Tobias Bäuerle, Christian M. Zechmann, Barbara Wa… , 2016. - 8 S.
In: European radiology, ISSN 1432-1084. 26(2016), 5, Seite 1404-1411
DOI: 10.1007/s00330-015-3928-4
Weinhold, Niels: The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells / Niels Weinhold, Tobias Meissner, David C Johnson, Anja Seckinger, Jérôme Moreaux, Asta Försti, Bowan… , 2015. - 4 S.
In: Haematologica, ISSN 1592-8721. 100(2015), 3, Seite e110-e113
DOI: 10.3324/haematol.2014.118786
Cowan, Graeme: Massive parallel IGHV gene sequencing reveals a germinal center pathway in origins of human multiple myeloma / Graeme Cowan, Nicola J. Weston-Bell, Dean Bryant, Anja Seckinger, Dirk Hose, Niklas Zojer, Surinder … , April 10, 2015. - 12 S.
In: OncoTarget, ISSN 1949-2553. 6(2015), 15, Seite 13229-13240
DOI: 10.18632/oncotarget.3644
Maes, Ken: In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma / Ken Maes, Eva De Smedt, Alboukadel Kassambara, Dirk Hose, Anja Seckinger, Els Van Valckenborgh, Elin… , 2015. - 16 S.
In: OncoTarget, ISSN 1949-2553. 6(2015), 5, Seite 3319-3334
DOI: 10.18632/oncotarget.3207
Bolomsky, Arnold: Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma / Arnold Bolomsky, Dirk Hose, Martin Schreder, Anja Seckinger, Susanne Lipp, Bernard Klein, Daniel Hei… , 08 February 2015. - 14 S.
In: Journal of hematology & oncology, ISSN 1756-8722. 8(2015)
DOI: 10.1186/s13045-014-0105-1
Wang, Lei: T cell-based targeted immunotherapies for patients with multiple myeloma / Lei Wang, Nan Jin, Anita Schmitt, Jochen Greiner, Georg Malcherek, Michael Hundemer, Jiju Mani, Dirk… , 2015. - 18 S.
In: International journal of cancer, ISSN 1097-0215. 136(2015), 8, Seite 1751-1768
DOI: 10.1002/ijc.29190
Bochtler, Tilmann: Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimens / Tilmann Bochtler, Ute Hegenbart, Christina Kunz, Martin Granzow, Axel Benner, Anja Seckinger, Christ… , 16 March 2015. - 8 S.
In: Journal of clinical oncology, ISSN 1527-7755. 33(2015), 12, Seite 1371-1378
DOI: 10.1200/JCO.2014.57.4947
Sachpekidis, Christos: 18F-FDG dynamic PET/CT in patients with multiple myeloma : Patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate / Christos Sachpekidis, MD, Elias K. Mai, MD, Hartmut Goldschmidt, MD, Jens Hillengass, MD, Dirk Hose,… , January 23, 2015. - 8 S.
In: Clinical nuclear medicine, ISSN 1536-0229. 40(2015), 6, Seite e300-e307
DOI: 10.1097/RLU.0000000000000773
Mai, Elias K.: A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myeloma / Elias K. Mai, Thomas Hielscher, Jost K. Kloth, Maximilian Merz, Sofia Shah, Marc S. Raab, Michaela H… , June 2015. - 8 S.
In: Haematologica, ISSN 1592-8721. 100(2015), 6, Seite 818-825
DOI: 10.3324/haematol.2015.124115
Merz, Maximilian: Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma : an interim analysis from the prospective GMMG-MM5 trial / Maximilian Merz, Hans Salwender, Mathias Haenel, Elias K. Mai, Uta Bertsch, Christina Kunz, Thomas H… , July 2015. - 6 S.
In: Haematologica, ISSN 1592-8721. 100(2015), 7, Seite 964-969
DOI: 10.3324/haematol.2015.124347
Clemens, Jannick: Cellular uptake kinetics of bortezomib in relation to efficacy in myeloma cells and the influence of drug transporters / Jannick Clemens, Anja Seckinger, Dirk Hose, Dirk Theile, Magdalena Longo, Walter Emil Haefeli, Jürge… , 2015. - 11 S.
In: Cancer chemotherapy and pharmacology, ISSN 1432-0843. 75(2015), 2, Seite 281-291
DOI: 10.1007/s00280-014-2643-1
Striegler, Christin: Dendritic glycopolymer as drug delivery system for proteasome inhibitor bortezomib in a calcium phosphate bone cement : first steps toward a local therapy of osteolytic bone lesions / Christin Striegler, Matthias Schumacher, Christiane Effenberg, Martin Müller, Anja Seckinger, Reinha… , September 2015. - 13 S.
In: Macromolecular bioscience, ISSN 1616-5195. 15(2015), 9, Seite 1283-1295
DOI: 10.1002/mabi.201500085
Kassambara, Alboukadel: GenomicScape : an easy-to-use web tool for gene expression data analysis : application to investigate the molecular events in the differentiation of b cells into plasma cells / Alboukadel Kassambara, Thierry Rème, Michel Jourdan, Thierry Fest, Dirk Hose, Karin Tarte, Bernard K… , January 29, 2015. - 10 S.
In: PLoS Computational Biology, ISSN 1553-7358. 11(2015) Artikel-Nummer e1004077, 10 Seiten
DOI: 10.1371/journal.pcbi.1004077
Waizenegger, Jonas S.: Role of growth arrest-specific gene 6-Mer axis in multiple myeloma / JS Waizenegger, I Ben-Batalla, N Weinhold, T Meissner, M Wroblewski, M Janning, K Riecken, M Binder,… , 2015. - 10 S.
In: Leukemia, ISSN 1476-5551. 29(2015), 3, Seite 696-704
DOI: 10.1038/leu.2014.236
Wu, Ping: A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescue / Ping Wu, Brian A. Walker, Annemiek Broyl, Martin Kaiser, David C. Johnson, Rowan Kuiper, Mark van Du… , 2015. - 9 S.
In: Leukemia and lymphoma, ISSN 1029-2403. 56(2015), 3, Seite 594-601
DOI: 10.3109/10428194.2014.911863
Merz, Maximilian: Dynamic contrast-enhanced magnetic resonance imaging for assessment of antiangiogenic treatment effects in multiple myeloma / Maximilian Merz, Judith Ritsch, Christina Kunz, Barbara Wagner, Sandra Sauer, Dirk Hose, Thomas Moeh… , 1 January 2015. - 7 S.
In: Clinical cancer research, ISSN 1557-3265. 21(2015), 1, Seite 106-112
DOI: 10.1158/1078-0432.CCR-14-1029
Seckinger, Anja: miRNAs in multiple myeloma : a survival relevant complex regulator of gene expression / Anja Seckinger, Tobias Meißner, Jérôme Moreaux, Vladimir Benes, Jens Hillengass, Mirco Castoldi, Jür… , 17 November 2015. - 19 S.
In: OncoTarget, ISSN 1949-2553. 6(2015), 36, Seite 39165-39183
DOI: 10.18632/oncotarget.5381
Meißner, Tobias: Profound impact of sample processing delay on gene expression of multiple myeloma plasma cells / Tobias Meißner, Anja Seckinger, Kari Hemminki, Uta Bertsch, Asta Försti, Mathias Hänel, Jan Duering,… . -
London: BioMed Central, 2016. - 1 Online-Ressource (8 Seiten)
DOI: 10.1186/s12920-015-0161-6
Mai, Elias K.: Phase III trial of bortezomib, cyclophosphamide, dexamethasone (VCD) versus bortezomib, doxorubicin, dexamethasone (PAd) in newly-diagnosed myeloma / E. K. Mai, U. Bertsch, J. Dürig, C. Kunz, M. Haenel, I. W. Blau, M. Munder, A. Jauch, B. Schurich, T… , 2015
In: Leukemia, ISSN 1476-5551. 29(2015), 8, Seite 1721-1729
DOI: 10.1038/leu.2015.80
Weinhold, Niels: Inherited genetic susceptibility to monoclonal gammopathy of unknown significance / Niels Weinhold, David C. Johnson, Andrew C. Rawstron, Asta Försti, Chi Doughty, Jayaram Vijayakrishn… , January 21, 2014. - 5 S.
In: Blood, ISSN 1528-0020. 123(2014), 16, Seite 2513-2517
DOI: 10.1182/blood-2013-10-532283
Merz, Maximilian: Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma / M. Merz, T. Hielscher, B. Wagner, S. Sauer, S. Shah, M. S. Raab, A. Jauch, K. Neben, D. Hose, G. Ege… , [2014]. - 7 S.
In: Leukemia, ISSN 1476-5551. 28(2014), 9, Seite 1902-1908
DOI: 10.1038/leu.2014.75
Wagner, Verena: Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1 / Verena Wagner, Dirk Hose, Anja Seckinger, Ludmila Weiz, Tobias Meißner, Thiery Rème, Iris Breitkreut… , September 26, 2014. - 14 S.
In: OncoTarget, ISSN 1949-2553. 5(2014), 21, Seite 10237-10250
DOI: 10.18632/oncotarget.2529
Sachpekidis, Christos: PET/CT studies of multiple myeloma using 18 F-FDG and 18 F-NaF : comparison of distribution patterns and tracers’ pharmacokinetics / Christos Sachpekidis, Hartmut Goldschmidt, Dirk Hose, Leyun Pan, Caixia Cheng, Klaus Kopka, Uwe Habe… , 22 February 2014. - 11 S.
In: European journal of nuclear medicine and molecular imaging, ISSN 1619-7089. 41(2014), 7, Seite 1343-1353
DOI: 10.1007/s00259-014-2721-y
Hassen, Wafa: Drug metabolism and clearance system in tumor cells of patients with multiple myeloma / Wafa Hassen, Alboukadel Kassambara, Thierry Reme, Surinder Sahota, Anja Seckinger, Laure Vincent, Gu… , 2015. - 17 S.
In: OncoTarget, ISSN 1949-2553. 6(2015), 8, Seite 6431-6447
DOI: 10.18632/oncotarget.3237
Kassambara, Alboukadel: A DNA repair pathway score predicts survival in human multiple myeloma : the potential for therapeutic strategy / Alboukadel Kassambara, Claire Gourzones-Dmitriev, Surinder Sahota, Thierry Rème, Jérôme Moreaux, Har… , 2014 May. - 12 S.
In: OncoTarget, ISSN 1949-2553. 5(2014), 9, Seite 2487-2498
DOI: 10.18632/oncotarget.1740
Clemens, Jannick: Stability of the proteasome inhibitor bortezomib in cell based assays determined by ultra-high performance liquid chromatography coupled to tandem mass spectrometry / Jannick Clemens, Magdalena Longo, Anja Seckinger, Dirk Hose, Walter Emil Haefeli, Johanna Weiss, Jür… , 6 June 2014. - 11 S.
In: Journal of chromatography, ISSN 1873-3778. 1345(2014), Seite 128-138
DOI: 10.1016/j.chroma.2014.04.024
Bolomsky, Arnold: Immunomodulatory drugs thalidomide and lenalidomide affect osteoblast differentiation of human bone marrow stromal cells in vitro / Arnold Bolomsky, Martin Schreder, Tobias Meißner, Dirk Hose, Heinz Ludwig, Sabine Pfeifer, and Nikla… , July 2014. - 10 S.
In: Experimental hematology, ISSN 1873-2399. 42(2014), 7, Seite 516-525
DOI: 10.1016/j.exphem.2014.03.005
Jourdan, Michel: IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors / M. Jourdan, M. Cren, N. Robert, K. Bolloré, T. Fest, C. Duperray, F. Guilloton, D. Hose, K. Tarte an… . - 10 S.
In: Leukemia, ISSN 1476-5551. 28(2014), 8, S. 1647-1656
DOI: 10.1038/leu.2014.61
Hose, Dirk: Biologie des multiplen Myeloms / D. Hose, A. Seckinger. - 9 S.
In: Der Onkologe, ISSN 1433-0415. 20(2014), 3, S. 208-216
DOI: 10.1007/s00761-013-2568-z
Bochtler, Tilmann: Gain of chromosome 1q21 is an independent adverse prognostic factor in light chain amyloidosis patients treated with melphalan/dexamethasone / Tilmann Bochtler, Ute Hegenbart, Christina Kunz, Axel Benner, Anja Seckinger, Sascha Dietrich, Marti… , 2014. - 9 S.
In: Amyloid, ISSN 1744-2818. 21(2014), 1, Seite 9-17
DOI: 10.3109/13506129.2013.854766
Weinhold, Niels: Immunoglobulin light-chain amyloidosis shares genetic susceptibility with multiple myeloma / N. Weinhold, A. Försti, M. I. da Silva Filho, J. Nickel, C. Campo, P. Hoffmann, M. M. Nöthen, D. Hos… , 2014. - 3 S.
In: Leukemia, ISSN 1476-5551. 28(2014), 11, Seite 2254-2256
DOI: 10.1038/leu.2014.208
Seckinger, Anja: Interaktion zwischen Myelomzellen und Knochengewebe / A. Seckinger, D. Hose. - 6 S.
In: Der Radiologe, ISSN 1432-2102. 54(2014), 6, S. 545-550
DOI: 10.1007/s00117-013-2626-y
Schönland, Stefan: Detection and characterization of plasma cell and B cell clones in patients with systemic light chain amyloidosis using flow cytometry / Stefan Schönland, Ute Hegenbart, Christoph Kimmich, Katarina Lisenko, Dirk Hose, Hartmut Goldschmidt… , 2014. - 1 S.
In: Blood, ISSN 1528-0020. 124(2014), 21
Scheid, Christoph: Influence of renal impairment and genetic risk factors on response to Induction therapy in the HD4 and MM5 trials of the GMMG / Christof Scheid, Thomas Hielscher, Uta Bertsch, Christina Kunz, Hans Salwender, Mathias Haenel, Maxi… , 2014. - 1 S.
In: Blood, ISSN 1528-0020. 124(2014), 21
Merz, Maximilian: Subcutaneous versus intravenous bortezomib in two different induction therapies for fewly diagnosed multiple myeloma : Elektronische Ressource$dsubgroup analysis from the GMMG-MM5 trial / Maximilian Merz, Hans Salwender, Mathias Hänel, Uta Bertsch, Christina Kunz, Thomas Hielscher, Igor … , 2014. - 1 S.
In: Blood, ISSN 1528-0020. 124(2014), 21, Artikel-ID 71052
Maes, Ken: The in vivo transcriptional response towards epigenetic modulating agents in multiple myeloma / Ken Maes, Eva De Smedt, Kassambara Alboukadel, Dirk Hose, Anja Seckinger, Els Van Valckenborgh, Elin… , 2014. - 1 S.
In: Blood, ISSN 1528-0020. 124(2014,21) Artikel-Nr. 72054, 1 S.
Hájek, Roman: Prediction of progression of smouldering into therapy requiring multiple myeloma by easily accessible clinical factors [in 527 patients] / Roman Hajek, Viera Sandecka, Anja Seckinger, Ivan Spicka, Vlastimil Scudla, Evzen Gregora, Jakub Rad… , 2014. - 1 S.
In: Blood, ISSN 1528-0020. 124(2014,21) Artikel-Nr. 2071, 1 S.
Hose, Dirk: Experimental and conceptual basis for personalized and risk-adapted treatment of multiple myeloma / vorgelegt von Dirk Hose, 2013 [ersch.] 2014. - Getr. Zählung : Ill., graph. Darst.
Merz, Maximilian: Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents / Merz, M.; Neben, K.; Raab, M. S.; Sauer, S.; Egerer, G.; Hundemer, M.; Hose, D.; Kunz, C.; Heiss, C.… , 2014. - 7 S.
In: Annals of oncology, ISSN 1569-8041. 25(2014), 1, Seite 189-195
DOI: 10.1093/annonc/mdt509
Moreaux, Jérôme: DNA methylation score is predictive of myeloma cell sensitivity to 5-azacitidine / Moreaux, Jerome ; Bruyer, Angelique ; Veyrune, Jean-Luc ; Goldschmidt, Hartmut ; Hose, Dirk ; Klein,… . - 4 S.
In: British journal of haematology, ISSN 1365-2141. 164(2014), 4, S. 613-616
DOI: 10.1111/bjh.12660
Rème, Thierry: Modeling risk stratification in human cancer / Thierry Rème, Dirk Hose, Charles Theillet and Bernard Klein, March 14, 2013. - 9 S.
In: Bioinformatics, ISSN 1367-4811. 29(2013), 9 vom: 1. Mai, Seite 1149-1157
DOI: 10.1093/bioinformatics/btt124
Neben, Kai: Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load / Kai Neben, Anna Jauch, Thomas Hielscher, Jens Hillengass, Nicola Lehners, Anja Seckinger, Martin Gra… , October 21, 2013. - 9 S.
In: Journal of clinical oncology, ISSN 1527-7755. 31(2013), 34, Seite 4325-4332
DOI: 10.1200/JCO.2012.48.4923
Witzens-Harig, Mathias: Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6 / Mathias Witzens-Harig, Dirk Hose, Simone Jünger, Christina Pfirschke, Nisit Khandelwal, Ludmila Uman… , April 19, 2013. - 11 S.
In: Blood, ISSN 1528-0020. 121(2013), 22, Seite 4493-4503
DOI: 10.1182/blood-2012-05-429415
Weinhold, Niels: The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma / Niels Weinhold, David C. Johnson, Daniel Chubb, Bowang Chen, Asta Försti, Fay J. Hosking, Peter Brod… , 17 March 2013. - 5 S.
In: Nature genetics, ISSN 1546-1718. 45(2013), 5, Seite 522-526
DOI: 10.1038/ng.2583
Sellner, Leopold: Autologous retransplantation for patients with recurrent multiple myeloma : a single-center experience with 200 patients / Leopold Sellner, Christiane Heiss, Axel Benner, Marc S. Raab, Jens Hillengass, Dirk Hose, Nicola Leh… , April 10, 2013. - 9 S.
In: Cancer, ISSN 1097-0142. 119(2013), 13, Seite 2438-2446
DOI: 10.1002/cncr.28104
Yordanova, Anna: Sorafenib in patients with refractory or recurrent multiple myeloma / Anna Yordanova, Dirk Hose, Kai Neben, Mathias Witzens-Harig, Ines Gütgemann, Marc-Steffen Raab, Thom… , 15 March 2013. - 4 S.
In: Hematological oncology, ISSN 1099-1069. 31(2013), 4, Seite 197-200
DOI: 10.1002/hon.2043
Schoenhals, Matthieu: Krüppel-like factor 4 blocks tumor cell proliferation and promotes drug resistance in multiple myeloma / Matthieu Schoenhals, Alboukadel Kassambara, Jean-Luc Veyrune, Jerome Moreaux, Hartmut Goldschmidt, D… , 2013 Apr 12. - 8 S.
In: Haematologica, the hematology journal, ISSN 1592-8721. 98(2013), 9, Seite 1442-1449
DOI: 10.3324/haematol.2012.066944
Schmitt, Stefan: Bisphosphonate treatment and renal function in 201 myeloma patients undergoing stem cell transplantation / S. Schmitt, T. Hielscher, C. Baldus, K. Neben, G. Egerer, J. Hillengaß, M. Raab, D. Hose, A.D. Ho, R… , 25 April 2013. - 8 S.
In: International journal of hematology, ISSN 1865-3774. 97(2013), 6, Seite 765-772
DOI: 10.1007/s12185-013-1320-1
Moreaux, Jérôme: Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors / J. Moreaux, T. Reme, W. Leonard, J.-L. Veyrune, G. Requirand, H. Goldschmidt, D. Hose and B. Klein, 18 July 2013. - 10 S.
In: British journal of cancer, ISSN 1532-1827. 109(2013), 3, Seite 676-685
DOI: 10.1038/bjc.2013.392
Möhler, Thomas: The glycome of normal and malignant plasma cells / Thomas M. Moehler, Anja Seckinger, Dirk Hose, Mindaugas Andrulis, Jèrôme Moreaux, Thomas Hielscher, … , December 26, 2013. - 13 S.
In: PLOS ONE, ISSN 1932-6203. 8(2013), 12, Artikel-ID e83719, Seite 1-13
DOI: 10.1371/journal.pone.0083719
Kassambara, Alboukadel: Inhibition of DEPDC1A, a bad prognostic marker in multiple myeloma, delays growth and induces mature plasma cell markers in malignant plasma cells / Alboukadel Kassambara, Matthieu Schoenhals, Jérôme Moreaux, Jean-Luc Veyrune, Thierry Rème, Hartmut … , April 30, 2013. - 13 S.
In: PLOS ONE, ISSN 1932-6203. 8(2013), 4 vom: Apr., Artikel-ID e62752, Seite 1-13
DOI: 10.1371/journal.pone.0062752
Gourzones-Dmitriev, Claire: DNA repair pathways in human multiple myeloma : role in oncogenesis and potential targets for treatment / Claire Gourzones-Dmitriev, Alboukadel Kassambara, Surinder Sahota, Thierry Rème, Jérôme Moreaux, Pas… , 09 Aug 2013. - 14 S.
In: Cell cycle, ISSN 1551-4005. 12(2013), 17, Seite 2760-2773
DOI: 10.4161/cc.25951
Chubb, Daniel: Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk / Daniel Chubb; Niels Weinhold ... Dirk Hose ... Kai Neben ... Elisabeth Dörner ... Anna Jauch ... Har… , 2013. - 5 S.
In: Nature genetics, ISSN 1546-1718. 45(2013), Seite 1221-1225
DOI: 10.1038/ng.2733
Broyl, Annemiek: High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance / Annemiek Broyl, Rowan Kuiper, Mark van Duin, Bronno van der Holt, Laila el Jarari, Uta Bertsch, Sonj… , 2013. - 4 S.
In: Blood, ISSN 1528-0020. 121(2013), 4, Seite 624-627
DOI: 10.1182/blood-2012-06-438101
Sonneveld, Pieter: Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma : results of the randomized phase III HOVON-65/ GMMG-HD4 trial / Pieter Sonneveld, Ingo G.H. Schmidt-Wolf, Bronno van der Holt, Laila el Jarari, Uta Bertsch, Hans Sa… , July 16, 2012. - 10 S.
In: Journal of clinical oncology, ISSN 1527-7755. 30(2012), 24, Seite 2946-2955
DOI: 10.1200/JCO.2011.39.6820
Kassambara, Alboukadel: Genes with a spike expression are clustered in chromosome (sub)bands and spike (sub)bands have a powerful prognostic value in patients with multiple myeloma / Alboukadel Kassambara, Dirk Hose, Jérôme Moreaux, Brian A. Walker, Alexei Protopopov, Thierry Reme, … . - 9 S.
In: Haematologica, the hematology journal, ISSN 1592-8721. 97(2012), 4, S. 622-630
DOI: 10.3324/haematol.2011.046821
Kassambara, Alboukadel: Identification of pluripotent and adult stem cell genes unrelated to cell cycle and associated with poor prognosis in multiple myeloma / Alboukadel Kassambara, Dirk Hose, Jérôme Moreaux, Thierry Rème, Jennifer Torrent, Jean François Ross…
In: PLOS ONE, ISSN 1932-6203. 7(2012,7) Artikel-Nummer 42161, 9 Seiten
DOI: 10.1371/journal.pone.0042161
Seckinger, Anja: Clinical and prognostic role of annexin A2 in multiple myeloma. / Anja Seckinger, Tobias Meiβner, Jérôme Moreaux, Daniela Depeweg, Jens Hillengass, Katja Hose, Thierr… . - 8 S.
In: Blood, ISSN 1528-0020. 120(2012), 5, S. 1087-94
DOI: 10.1182/blood-2012-03-415588
Hillengaß, Jens: Changes in magnetic resonance imaging before and after autologous stem cell transplantation correlate with response and survival in multiple myeloma / Jens Hillengass, Sofia Ayyaz, Kerstin Kilk, Marc-André Weber, Thomas Hielscher, Rajiv Shah, Dirk Hos… , 2012. - 4 S.
In: Haematologica, the hematology journal, ISSN 1592-8721. 97(2012), 11, Seite 1757-1760
DOI: 10.3324/haematol.2012.065359
Krämer, Isabelle: Thalidomide maintenance therapy maturates the T cell compartment and compromises antigen-specific antitumor immunity in patients with multiple myeloma / Isabelle Herth, Mathias Witzens-Harig, Philipp Beckhove, Dirk Hose, Tobias Meissner, Brigitte Neuber… , 2013. - 10 S.
In: Experimental hematology, ISSN 1873-2399. 41(2013), 3, Seite 231-240
DOI: 10.1016/j.exphem.2012.10.018
Moreaux, Jérôme: Development of gene expression-based score to predict sensitivity of multiple myeloma cells to DNA methylation inhibitors / Jérôme Moreaux, Thierry Rème, Wim Leonard, Jean-Luc Veyrune, Guilhem Requirand, Hartmut Goldschmidt,… . - 8 S.
In: Molecular cancer therapeutics, ISSN 1538-8514. 11(2012), 12, S. 2685-2692
DOI: 10.1158/1535-7163.MCT-12-0721
Moreaux, Jérôme: STEAP1 is overexpressed in cancers : A promising therapeutic target / Jerome Moreaux, Alboukadel Kassambara, Dirk Hose, Bernard Klein. - 8 S.
In: Biochemical and biophysical research communications, ISSN 0006-291X. 429(2012), 3, S. 148-155
DOI: 10.1016/j.bbrc.2012.10.123
Neben, Kai: Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p / Kai Neben, Henk M. Lokhorst, Anna Jauch, Uta Bertsch, Thomas Hielscher, Bronno van der Holt, Hans Sa… , January 26, 2012. - 9 S.
In: Blood, ISSN 1528-0020. 119(2012), 4, Seite 940-948
DOI: 10.1182/blood-2011-09-379164
Neben, Kai: Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p / Kai Neben ... Anna Jauch; Uta Bertsch ... Marc S. Raab; Anthony D. Ho ... Dirk Hose ... Hartmut Gold… , 2012. - 9 S.
In: Blood, ISSN 0006-4971. 119(2012), 4, Seite 940-948
Sonneveld, Pieter: Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma : results of the randomized phase III HOVON-65/ GMMG-HD4 trial / Pieter Sonneveld ... Uta Bertsch ... Dirk Hose; Anna Jauch ... Hartmut Goldschmidt, 2012. - 10 S.
In: Journal of clinical oncology, ISSN 0732-183X. 30(2012), 24, Seite 2946-2955
Neuber, Brigitte: Lenalidomide enhances antigen-specific activity and decreases CD45RA expression of T cells from patients with multiple myeloma / Brigitte Neuber, Isabelle Herth, Claudia Tolliver, Stefan Schoenland, Ute Hegenbart, Dirk Hose, Math… , July 6, 2011. - 10 S.
In: The journal of immunology, ISSN 1550-6606. 187(2011), 2, Seite 1047-1056
DOI: 10.4049/jimmunol.1002460
Moreaux, Jérôme: A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines / Jérôme Moreaux, Bernard Klein, Régis Bataille, Géraldine Descamps, Sophie Maïga, Dirk Hose, Hartmut … , 2011. - 9 S.
In: Haematologica, the hematology journal, ISSN 1592-8721. 96(2011), 4 vom: Apr., Seite 574-582
DOI: 10.3324/haematol.2010.033456
Moreaux, Jérôme: Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migration / Jerome Moreaux, Dirk Hose, Alboukadel Kassambara, Thierry Reme, Philippe Moine, Guilhem Requirand, H… , January 27, 2011. - 11 S.
In: Blood, ISSN 1528-0020. 117(2011), 4, Seite 1280-1290
DOI: 10.1182/blood-2010-04-279760
Klein, Ulrike: Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone / Ulrike Klein, Anna Jauch, Thomas Hielscher, Jens Hillengass, Marc S. Raab, Anja Seckinger, Dirk Hose… , 2011. - 9 S.
In: Cancer, ISSN 1097-0142. 117(2011), 10, Seite 2136-2144
DOI: 10.1002/cncr.25775
Meißner, Tobias: Gene expression profiling in multiple myeloma - reporting of entities, risk, and targets in clinical routine / Tobias Meißner, Anja Seckinger, Thierry Rème, Thomas Hielscher, Thomas Möhler, Kai Neben, Hartmut Go… , November 30 2011. - 8 S.
In: Clinical cancer research, ISSN 1557-3265. 17(2011), 23, Seite 7240-7247
DOI: 10.1158/1078-0432.CCR-11-1628
Jourdan, Michel: Characterization of a transitional preplasmablast population in the process of human B cell to plasma cell differentiation / Michel Jourdan, Anouk Caraux, Gersende Caron, Nicolas Robert, Geneviève Fiol, Thierry Rème, Karine B… , October 3, 2011. - 11 S.
In: The journal of immunology, ISSN 1550-6606. 187(2011), 8, Seite 3931-3941
DOI: 10.4049/jimmunol.1101230
Hose, Dirk: Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma / Dirk Hose, Thierry Rème, Thomas Hielscher, Jérôme Moreaux, Tobias Messner, Anja Seckinger, Axel Benn… , January, 2011. - 9 S.
In: Haematologica, the hematology journal, ISSN 1592-8721. 96(2011), 1, Seite 87-95
DOI: 10.3324/haematol.2010.030296
Bret, Caroline: SULFs in human neoplasia : implication as progression and prognosis factors / Caroline Bret, Jérôme Moreaux, Jean-François Schved, Dirk Hose and Bernard Klein, 21 May 2011. - 9 S.
In: Journal of translational medicine, ISSN 1479-5876. 9(2011), Artikel-ID 72, Seite 1-9
DOI: 10.1186/1479-5876-9-72
Bret, Caroline: Gene expression profile of ADAMs and ADAMTSs metalloproteinases in normal and malignant plasma cells and in the bone marrow environment / Caroline Bret, Dirk Hose, Thierry Reme, Alboukadel Kassambara, Anja Seckinger, Tobias Meißner, Jean-… , 11 February 2011. - 20 S.
In: Experimental hematology, ISSN 1873-2399. 39(2011), 5, Seite 546-557.e8
DOI: 10.1016/j.exphem.2011.02.002
Bochtler, Tilmann: Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14) / Tilmann Bochtler, Ute Hegenbart, Christiane Heiss, Axel Benner, Marion Moos, Anja Seckinger, Stephan… , April 7, 2011. - 7 S.
In: Blood, ISSN 1528-0020. 117(2011), 14, Seite 3809-3815
DOI: 10.1182/blood-2010-02-268987
Sprynski, A. C.: Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation / A.C. Sprynski, D. Hose, A. Kassambara, L. Vincent, M. Jourdan, J.F. Rossi, H. Goldschmidt and B. Kle… , 16 September 2010. - 11 S.
In: Leukemia, ISSN 1476-5551. 24(2010), 11, Seite 1940-1950
DOI: 10.1038/leu.2010.192
Fuhler, Gwenny M.: Bone marrow stromal cell interaction reduces Syndecan-1 expression and induces kinomic changes in myeloma cells / Gwenny M. Fuhler, Mirjam Baanstra, Daniel Chesik, Rajesh Somasundaram, Anja Seckinger, Dirk Hose, Ma… , 20 March 2010. - 13 S. : Illustrationen
In: Experimental cell research, ISSN 1090-2422. 316(2010), 11 vom: Juli, Seite 1816-1828
DOI: 10.1016/j.yexcr.2010.03.013
Moreaux, Jérôme: MYEOV is a prognostic factor in multiple myeloma / Jerome Moreaux, Dirk Hose, Amélie Bonnefond, Thierry Reme, Nicolas Robert, Hartmut Goldschmidt and B… , 18 September 2010. - 13 S.
In: Experimental hematology, ISSN 1873-2399. 38(2010), 12, Seite 1189-1198, e1-e3
DOI: 10.1016/j.exphem.2010.09.002
Caers, Jo: Thymosin β4 in multiple myeloma : friend or foe / Jo Caers, Eleonore Otjacques, Dirk Hose, Bernard Klein, and Karin Vanderkerken, 03 May 2010. - 5 S.
In: Annals of the New York Academy of Sciences, ISSN 1749-6632. 1194(2010) vom: Mai, Seite 125-129
DOI: 10.1111/j.1749-6632.2010.05470.x
Broyl, Annemiek: Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients / Annemiek Broyl, Dirk Hose, Henk Lokhorst, Yvonne de Knegt, Justine Peeters, Anna Jauch, Uta Bertsch,… , October 7, 2010. - 11 S.
In: Blood, ISSN 1528-0020. 116(2010), 14, Seite 2543-2553
DOI: 10.1182/blood-2009-12-261032
Weinhold, Niels: NPM1 is overexpressed in hyperdiploid multiple myeloma due to a gain of chromosome 5 but is not delocalized to the cytoplasm / Niels Weinhold, Jerome Moreaux, Marc S. Raab, Dirk Hose, Thomas Hielscher, Axel Benner, Tobias Meißn… , 13 January 2010. - 9 S.
In: Genes, chromosomes & cancer, ISSN 1098-2264. 49(2010), 4, Seite 333-341
DOI: 10.1002/gcc.20745
Neben, Kai: Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation / Kai Neben, Anna Jauch, Uta Bertsch, Christiane Heiss, Thomas Hielscher, Anja Seckinger, Tina Mors, N… , 2010 Jul. - 8 S. : Diagramme
In: Haematologica, the hematology journal, ISSN 1592-8721. 95(2010), 7, Seite 1150-1157
DOI: 10.3324/haematol.2009.016436
Mahtouk, Karène: Growth factors in multiple myeloma : a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays / Karène Mahtouk, Jérôme Moreaux, Dirk Hose, Thierry Rème, Tobias Meißner, Michel Jourdan, Jean Franço… , [2010]. - 18 S. : Illustrationen
In: BMC cancer, ISSN 1471-2407. 10(2010), Artikel-ID 198, Seite 1-18
DOI: 10.1186/1471-2407-10-198
Jourdan, Michel: Gene expression of anti- and pro-apoptotic proteins in malignant and normal plasma cells / Michel Jourdan, Thierry Reme, Hartmut Goldschmidt, Geneviève Fiol, Véronique Pantesco, John De Vos, … , 10 March 2009. - 14 S. : Illustrationen
In: British journal of haematology, ISSN 1365-2141. 145(2009), 1, Seite 45-58
DOI: 10.1111/j.1365-2141.2008.07562.x
Hose, Dirk: Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma / Dirk Hose, Thierry Rème, Tobias Meissner, Jérôme Moreaux, Anja Seckinger, Joe Lewis, Vladimir Benes,… , [April 30 2009]. - 10 S. : Illustrationen
In: Blood, ISSN 1528-0020. 113(2009), 18, Seite 4331-4340
DOI: 10.1182/blood-2008-09-178350
Sprynski, Anne Catherine: The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor / Anne Catherine Sprynski, Dirk Hose, Laurent Caillot, Thierry Réme, John D., Jr Shaughnessy, Bart Bar… , [May 7 2009]. - 13 S. : Illustrationen
In: Blood, ISSN 1528-0020. 113(2009), 19, Seite 4614-4626
DOI: 10.1182/blood-2008-07-170464
Hose, Dirk: Induction of angiogenesis by normal and malignant plasma cells / Dirk Hose, Jérôme Moreaux, Tobias Meissner, Anja Seckinger, Hartmut Goldschmidt, Axel Benner, Karène… , [2 July 2009]. - 16 S.
In: Blood, ISSN 1528-0020. 114(2009), 1, Seite 128-143
DOI: 10.1182/blood-2008-10-184226
Bret, Caroline: Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells / Caroline Bret, Dirk Hose, Thierry Reme, Anne-Catherine Sprynski, Karène Mahtouk, Jean-François Schve… , 06 April 2009. - 19 S. : Illustrationen
In: British journal of haematology, ISSN 1365-2141. 145(2009), 3, Seite 350-368
DOI: 10.1111/j.1365-2141.2009.07633.x
Christensen, Olaf: Melan-A/MART1 analog peptide triggers anti-myeloma T-cells through crossreactivity with HM1.24 / Olaf Christensen, Alaviana Lupu, Stefanie Schmidt, Maud Condomines, Sebastian Belle, Ariane Maier, D… , [July-August 2009]. - 9 S. : Illustrationen
In: Journal of immunotherapy, ISSN 1537-4513. 32(2009), 6, Seite 613-621
DOI: 10.1097/CJI.0b013e3181a95198
Hillengaß, Jens: Dynamic contrast-enhanced magnetic resonance imaging identifies a subgroup of patients with asymptomatic monoclonal plasma cell disease and pathologic microcirculation / Jens Hillengass, Christian Zechmann, Tobias Bäuerle, Barbara Wagner-Gund, Christiane Heiss, Axel Ben… , May 2009. - 8 S. : Illustrationen
In: Clinical cancer research, ISSN 1557-3265. 15(2009), 9, Seite 3118-3125
DOI: 10.1158/1078-0432.CCR-08-2310
Condomines, Maud: Gene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myeloma / Maud Condomines, Dirk Hose, Thierry Rème, Guilhem Requirand, Michael Hundemer, Matthieu Schoenhals, … , [2009]. - 9 S. : Diagramme
In: The journal of immunology, ISSN 1550-6606. 183(2009), 2, Seite 832-840
DOI: 10.4049/jimmunol.0803298
Seckinger, Anja: Bone morphogenic protein 6 : a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis / A. Seckinger, T. Meißner, J. Moreaux, H. Goldschmidt, G. M. Fuhler, A. Benner, M. Hundemer, T. Rème,… , 31 August 2009. - 14 S.
In: Oncogene, ISSN 1476-5594. 28(2009), 44, Seite 3866-3879
DOI: 10.1038/onc.2009.257
Caers, Jo: Thymosin β4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma / Jo Caers, Dirk Hose, Ine Kuipers, Tomas Jan Bos, Els Van Valckenborgh, Eline Menu, Elke De Bruyne, H… , [2010]. - 5 S.
In: Haematologica, the hematology journal, ISSN 1592-8721. 95(2010), 1, Seite 163-167
DOI: 10.3324/haematol.2009.006411
Rossi, Jean-François: Atacicept in relapsed/refractory multiple myeloma or active Waldenström's macroglobulinemia : a phase I study / J.-F. Rossi, J. Moreaux, D. Hose, G. Requirand, M. Rose, V. Rouillé, I. Nestorov, G. Mordenti, H. Go… , 29 September 2009. - 8 S. : Diagramme
In: British journal of cancer, ISSN 1532-1827. 101(2009), 7, Seite 1051-1058
DOI: 10.1038/sj.bjc.6605241
Hose, Dirk: Aurora-Kinase-Inhibition zur personalisierten und risikoadaptierten Therapie des Multiplen Myeloms / vorgelegt von Dirk Hose, 2009. - 87 S. : graph. Darst.
Rème, Thierry: A new method for class prediction based on signed-rank algorithms applied to Affymetrix microarray experiments / Thierry Rème, Dirk Hose, John De Vos, Aurélien Vassal, Pierre-Olivier Poulain, Véronique Pantesco, H… , 11 January 2008. - 12 S. : 1 Diagramm
In: BMC bioinformatics, ISSN 1471-2105. 9(2008), Artikel-ID 16, Seite 1-12
DOI: 10.1186/1471-2105-9-16
Belle, Sebastian: Identification of HLA-A2 restricted T-cell epitopes within the conserved region of the immunoglobulin G heavy-chain in patients with multiple myeloma / Sebastian Belle, Fang Han, Maud Condomines, Olaf Christensen, Mathias Witzens-Harig, Bernd Kasper, C… , 28 June 2008. - 10 S. : Diagramme
In: European journal of haematology, ISSN 1600-0609. 81(2008), 1, Seite 26-35
DOI: 10.1111/j.1600-0609.2008.01076.x
Bochtler, Tilmann: Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability / Tilmann Bochtler, Ute Hegenbart, Friedrich W. Cremer, Christiane Heiss, Axel Benner, Dirk Hose, Mari… , [1 May 2008]. - 6 S.
In: Blood, ISSN 1528-0020. 111(2008), 9, Seite 4700-4705
DOI: 10.1182/blood-2007-11-122101
Hillengaß, Jens: Gain of 1q21 and distinct adverse cytogenetic abnormalities correlate with increased microcirculation in multiple myeloma / Jens Hillengass, Christian M. Zechmann, Andreas Nadler, Dirk Hose, Friedrich W. Cremer, Anna Jauch, … , 19 March 2008. - 5 S. : Illustrationen
In: International journal of cancer, ISSN 1097-0215. 122(2008), 12, Seite 2871-2875
DOI: 10.1002/ijc.23455
Condomines, Maud: Cancer/testis genes in multiple myeloma : expression patterns and prognosis value determined by microarray analysis / Maud Condomines, Dirk Hose, Pierre Raynaud, Michael Hundemer, John De Vos, Marion Baudard, Thomas Mo… , [March 1, 2007]. - 9 S. : Illustrationen
In: The journal of immunology, ISSN 1550-6606. 178(2007), 5, Seite 3307-3315
DOI: 10.4049/jimmunol.178.5.3307
Mahtouk, Karène: Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma / Karène Mahtouk, Dirk Hose, Pierre Raynaud, Michael Hundemer, Michel Jourdan, Eric Jourdan, Veronique… , [1 June 2007]. - 10 S. : Illustrationen
In: Blood, ISSN 1528-0020. 109(2007), 11, Seite 4914-4923
DOI: 10.1182/blood-2006-08-043232
Hose, Dirk: Multiples Myelom - konventionelle Diagnostik / D. Hose, H. Goldschmidt, 2007. - 7 S.
In: Krebsmedizin, ISSN 1868-4246. 16(2007), Seite 6-12
Hose, Dirk: Multiples Myelom - innovative Diagnostik / D. Hose, U. Bertsch, H. Goldschmidt, 2007. - 5 S.
In: Krebsmedizin, ISSN 1868-4246. 16(2007), Seite 14-18
Moreaux, Jérôme: TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell lines / Jérôme Moreaux, Dirk Hose, Michel Jourdan, Thierry Reme, Michael Hundemer, Marion Moos, Nicolas Robe… , June, 2007. - 9 S. : Illustrationen
In: Haematologica, the hematology journal, ISSN 1592-8721. 92(2007), 6 vom: Juni, Seite 803-811
DOI: 10.3324/haematol.10574
Jourdan, Michel: Targeting NF-kappa B pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth / Michel Jourdan, Jérôme Moreaux, John De Vos, Dirk Hose, Karène Mahtouk, Matthieu Abouladze, Nicolas … , 03 June 2007. - 9 S. : Illustrationen
In: British journal of haematology, ISSN 1365-2141. 138(2007), 2, Seite 160-168
DOI: 10.1111/j.1365-2141.2007.06629.x
Mahtouk, Karène: Input of DNA Microarrays to Identify Novel Mechanisms in Multiple Myeloma Biology and Therapeutic Applications / Karène Mahtouk, Dirk Hose, John De Vos, Jérôme Moreaux, Michel Jourdan, Jean François Rossi, Thierry… , December 2007. - 7 S. : Illustrationen
In: Clinical cancer research, ISSN 1557-3265. 13(2007), 24, Seite 7289-7295
DOI: 10.1158/1078-0432.CCR-07-1758
Hundemer, Michael: Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14) / M. Hundemer, U. Klein, D. Hose, M.-S. Raab, F. W. Cremer, A. Jauch, A. Benner, C. Heiss, M. Moos, A.… , 24 September 2007. - 5 S. : Diagramme
In: Bone marrow transplantation, ISSN 1476-5365. 40(2007), 11, Seite 1033-1037
DOI: 10.1038/sj.bmt.1705857
Mahtouk, Karène: Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma / K. Mahtouk, F.W. Cremer, T. Rème, M. Jourdan, M. Baudard, J. Moreaux, G. Requirand, G. Fiol, J. De V… , 29 May 2006. - 12 S.
In: Oncogene, ISSN 1476-5594. 25(2006), 54, Seite 7180-7191
DOI: 10.1038/sj.onc.1209699
Moreaux, Jérôme: CD200 is a new prognostic factor in multiple myeloma / Jerome Moreaux, Dirk Hose, Thierry Reme, Eric Jourdan, Michael Hundemer, Eric Legouffe, Philippe Moi… , [2006]. - 4 S. : Diagramme
In: Blood, ISSN 1528-0020. 108(2006), 13, Seite 4194-4197
DOI: 10.1182/blood-2006-06-029355
De Vos, John: Microarray-based understanding of normal and malignant plasma cells / John De Vos, Dirk Hose, Thierry Rème, Karin Tarte, Jérôme Moreaux, Karéne Mahtouk, Michel Jourdan, H… , 28 March 2006. - 19 S.
In: Immunological reviews, ISSN 1600-065X. 210(2006), 1, Seite 86-104
DOI: 10.1111/j.0105-2896.2006.00362.x
Hundemer, Michael: Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma / Michael Hundemer, Stefanie Schmidt, Maud Condomines, Alaviana Lupu, Dirk Hose, Marion Moos, Friedric… , [April 2006]. - 11 S. : Diagramme
In: Experimental hematology, ISSN 1873-2399. 34(2006), 4 vom: Apr., Seite 486-496
DOI: 10.1016/j.exphem.2006.01.008
Mahtouk, Karène: Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells / Karène Mahtouk, Dirk Hose, Thierry Rème, John De Vos, Michel Jourdan, Jérôme Moreaux, Geneviève Fiol… , 28 February 2005. - 13 S.
In: Oncogene, ISSN 1476-5594. 24(2005), 21 vom: Feb., Seite 3512-3524
DOI: 10.1038/sj.onc.1208536
Moreaux, Jérôme: The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature / Jérôme Moreaux, Friedrich W. Cremer, Thierry Reme, Marc Raab, Karene Mahtouk, Philine Kaukel, Veroni… , [August 1 2005]. - 10 S. : Illustrationen
In: Blood, ISSN 1528-0020. 106(2005), 3 vom: Aug., Seite 1021-1030
DOI: 10.1182/blood-2004-11-4512
Cremer, Friedrich Walter: High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISH / Friedrich W. Cremer, Mutlu Kartal, Dirk Hose, Jelena Bila, Isabelle Buck, Frauke Bellos, Marc-Steffe… , [September 2005]. - 9 S. : Illustrationen
In: Cancer genetics and cytogenetics, ISSN 1873-4456. 161(2005), 2 vom: Sept., Seite 116-124
DOI: 10.1016/j.cancergencyto.2005.02.015
Cremer, Friedrich Walter: Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics / Friedrich W. Cremer, Jelena Bila, Isabelle Buck, Mutlu Kartal, Dirk Hose, Carina Ittrich, Axel Benne… , 06 July 2005. - 10 S.
In: Genes, chromosomes & cancer, ISSN 1098-2264. 44(2005), 2, Seite 194-203
DOI: 10.1002/gcc.20231
Hose, Dirk: Multiples Myelom / Dirk Hose, Friedrich Walter Cremer, Hartmut Goldschmidt, 2005. - 10 S.
In: Spektrum der Nephrologie, ISSN 0935-400X. 18(2005), Seite 14-23

IDs

GND:

139824995

Links

Hose, Dirk in ...

Export Publikationsliste

heiBIB

Bei fehlerhaften oder unvollständigen Angaben wenden Sie sich bitte an biblio@ub.uni-heidelberg.de.

Informationen zu heiBIB (inkl. Einbettung der Publikationslisten in eigene WWW-Seiten).

Impressum / Datenschutz Design